CASC sells 26.7M shares @$3.30—a 10% discount to yesterday’s close: http://finance.yahoo.com/news/cascadian-therapeutics-prices-82-5-135046454.html Concurrently, CASC sold $6M of convertible preferred stock. *Assuming exercise of underwriter’s option.